These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28340223)

  • 1. Implantation of cardiac resynchronization therapy devices using three leads by cephalic vein dissection approach.
    Hadjis A; Proietti R; Essebag V
    Europace; 2017 Sep; 19(9):1514-1520. PubMed ID: 28340223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified cardiac resynchronization implantation technique involving right access and a triple-guide/single introducer approach.
    Romeyer-Bouchard C; Da Costa A; Abdellaoui L; Messier M; Thévenin J; Afif Z; Samuel B; Kihel A; Cerisier A; Convert G; Isaaz K
    Heart Rhythm; 2005 Jul; 2(7):714-9. PubMed ID: 15992727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple lead cephalic versus subclavian vein approach in cardiac resynchronization therapy device implantation.
    Vogler J; Geisler A; Gosau N; Hakmi S; Willems S; Rassaf T; Wakili R; Kaya E
    Sci Rep; 2018 Dec; 8(1):17709. PubMed ID: 30532064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalic vein access by modified Seldinger technique for lead implantations.
    Rademakers LM; Bracke FA
    Pacing Clin Electrophysiol; 2021 Apr; 44(4):607-613. PubMed ID: 33609409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary vein puncture guided by ultrasound vs cephalic vein dissection in pacemaker and defibrillator implant: A multicenter randomized clinical trial.
    Tagliari AP; Kochi AN; Mastella B; Saadi RP; di Leoni Ferrari A; Saadi EK; Polanczyk CA
    Heart Rhythm; 2020 Sep; 17(9):1554-1560. PubMed ID: 32360827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroscopy-guided axillary vein access vs cephalic vein access in pacemaker and defibrillator implantation: Randomized clinical trial of efficacy and safety.
    Jiménez-Díaz J; Higuera-Sobrino F; Piqueras-Flores J; Pérez-Díaz P; González-Marín MA
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1588-1593. PubMed ID: 31310038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of cephalic venous access for cardiac resynchronization device implantation.
    Ussen B; Dhillon PS; Anderson L; Beeton I; Hickman M; Gallagher MM
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):365-9. PubMed ID: 21091741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusively cephalic venous access for cardiac resynchronisation: A prospective multi-centre evaluation.
    Harding I; Mannakkar N; Gonna H; Domenichini G; Leung LW; Zuberi Z; Bajpai A; Lalor J; Cox AT; Li A; Sohal M; Chen Z; Beeton I; Gallagher MM
    Pacing Clin Electrophysiol; 2020 Dec; 43(12):1515-1520. PubMed ID: 32860243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac implantable electronic devices in patients with persistent left superior vena cava-A single center experience.
    Ghazzal B; Sabayon D; Kiani S; Leon AR; Delurgio D; Patel AM; Lloyd MS; Westerman S; Shah A; Merchant FM; El-Chami MF
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1175-1181. PubMed ID: 32237003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-taught axillary vein access without venography for pacemaker implantation: prospective randomized comparison with the cephalic vein access.
    Squara F; Tomi J; Scarlatti D; Theodore G; Moceri P; Ferrari E
    Europace; 2017 Dec; 19(12):2001-2006. PubMed ID: 28064251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
    Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
    Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-lead cephalic venous access and long-term performance of high-voltage leads.
    Akhtar Z; Harding I; Elbatran AI; Gonna H; Mannakkara NN; Leung LWM; Zuberi Z; Bajpai A; Pearse S; Cox AT; Li A; Jouhra F; Valencia O; Chen Z; Sohal M; Beeton I; Gallagher MM
    J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1131-1139. PubMed ID: 33565195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoral implantation and pull through as an adjunct to traditional methods in cardiac resynchronization therapy.
    Gonna H; Domenichini G; Zuberi Z; Adhya S; Sharma R; Anderson LJ; Beeton I; Dhillon PS; Gallagher MM
    Heart Rhythm; 2016 Jun; 13(6):1260-5. PubMed ID: 26820509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.